ASO Author Reflections: Identification of Prognostic Factors for Stage-III Pancreatic Ductal Adenocarcinoma patients

Ann Surg Oncol. 2022 Mar;29(3):1616-1617. doi: 10.1245/s10434-021-11041-7. Epub 2021 Nov 20.
No abstract available

MeSH terms

  • Carcinoma, Pancreatic Ductal* / therapy
  • Humans
  • Pancreatic Neoplasms* / therapy
  • Prognosis